Skip to main content
LNSR logo

LENSAR, Inc.

LNSRNASDAQHealthcareMedical Devices

$6.02Today:- (-)1Y −49.75%

As of Oct 22, 2026 close

Market cap
$138.62M
P/E (TTM)
3.75
Forward P/E
-
Dividend yield
-
52-week range
$4.95$12.94
Volume (live)
-
Avg. volume (3M)
52.92K

LENSAR (LNSR) Stock Price & Financial Analysis

LENSAR Stock Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Price & Trading Activity
Day's Range$5.69 - $6.09
52-Week High$12.94
52-Week Low$4.95
Open$5.69
Volume (last close)163.21K
Average Volume (3M)52.92K
Earnings & Profitability
Revenue (TTM)61.97M
Net Income (TTM)36.95M
Free Cash Flow (TTM)-3.20M
EPS (TTM)$2.36
Profit Margin59.62%
Operating Margin-8.82%
Return on Equity (ROE)247.91%
Debt to Equity0.16
Dividend Information
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Size & Valuation
Market Cap138.62M
Shares Outstanding23.03M
P/E Ratio (TTM)3.75
Price to Sales (P/S)2.24
Price to Book (P/B)9.30
EV/EBITDA3.70
Technical Indicators
50-Day MA$7.40
200-Day MA$7.68
1-Year Change−49.75%

Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology

Compare LNSR with other stocks

LENSAR at a Glance

As of the Oct 22, 2026 close, LENSAR (LNSR) has a market capitalization of $138.62M. The stock trades at 3.8× trailing earnings and 2.2× sales. Over the trailing twelve months it earned $36.95M on revenue of $61.97M (a 59.6% profit margin) and burned $3.20M of free cash flow. Revenue grew 4.8% year over year.

As of its latest reported balance sheet, it holds $13.56M in cash and securities against $2.38M of debt, a net cash position of $11.18M.

LENSAR does not currently pay a dividend.

The share price is down 49.7% over the past year. At $6.02 (the Oct 22, 2026 close) it sits near the bottom of its 52-week range of $4.95 to $12.94, below its 200-day moving average of $7.68.

Frequently Asked Questions About LENSAR

What is the current stock price for LNSR?

As of the Oct 22, 2026 close, LNSR stock trades at $6.02. The 52-week range is $4.95–$12.94, with a day range of $5.69–$6.09.

What is the P/E ratio for LNSR?

As of the Oct 22, 2026 close, LENSAR's trailing twelve-month (TTM) P/E ratio is 3.8, meaning investors pay $3.8 for every $1 of annual earnings. LENSAR operates in the Healthcare sector.

Does LNSR pay dividends?

LENSAR does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.

What do analysts recommend for LNSR?

Analyst ratings and recommendations for LNSR are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of LNSR?

As of the Oct 22, 2026 close, LENSAR's market capitalization is $138.6M, classifying it as a micro-cap company. LENSAR operates in the Healthcare sector within the Medical Devices industry.